DOCSLIB.ORG

Targeted-Sequencing Gene Panels Used by Each Hospital Huashan

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Targeted-Sequencing Gene Panels Used by Each Hospital Huashan BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Med Genet Targeted-sequencing gene panels used by each hospital Huashan Hospital Fudan University ALG13 CACNA1S CAV3 CLCN1 KCNA2 KCNE3 KCNJ18 ABHD5 ACADL ACADM ACADS ACADVL ACTA1 ACTN3 ACVR1 ADCK3 AGK AGL AGRN ALDOA ALG14 ALG2 ANO5 ARFGAP2 ATP2A1 B3GALNT2 B3GNT1 B4GALT1 B4GAT1 BAG3 BIN1 BOLA3 C10orf2 CAPN3 CASQ1 CCDC78 CELF1 CFL2 CHAT CHCHD10 CHKB CHRNA1 CHRNB1 CHRND CHRNE CHRNG CKM CMYA5 CNBP CNTN1 COL12A1 COL6A1 COL6A2 COL6A3 COLQ COQ2 COQ6 COQ9 CPT2 CRYAB CSRP3 DAG1 DES DMD DMPK DNAJB6 DNM2 DOK7 DOLK DPAGT1 DPM1 DPM2 DPM3 DUX4 DYSF EMD ENO3 EPM2A ETFA ETFB ETFDH ETHE1 FBXO32 FHL1 FHL2 FKRP FKTN FLNC GAA GBE1 GFPT1 GMPPB GNE GYG1 GYS1 HACD1 HADH HINT1 HNRNPL HSPG2 ISCU ISPD ITGA7 ITGA9 KBTBD13 KLHL40 KLHL41 KLHL9 KY LAMA2 LAMB2 LAMP1 LAMP2 LARGE LDB3 LDHA LDHB LIFR LIMS2 LMNA LPIN1 LRP4 MATR3 MBNL1 MBNL2 MBNL3 MEGF10 MICU1 MSTN MTM1 MTMR14 MUSK MYBPC1 MYBPC2 MYBPC3 MYH1 MYH2 MYH3 MYH4 MYH7 Zhong H, et al. J Med Genet 2020;0:1–8. doi: 10.1136/jmedgenet-2020-107159 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Med Genet MYH8 MYL1 MYL10 MYL12A MYL12B MYL2 MYL3 MYL4 MYL5 MYL6 MYL6B MYL7 MYL9 MYLIP MYLK MYLK2 MYLK3 MYLK4 MYLPF MYOM1 MYOM2 MYOM3 MYOT MYOZ1 MYOZ2 MYOZ3 MYPN NBR1 NEB NEBL NHLRC1 NTRK1 OBSCN OBSL1 OPA1 ORAI1 PABPN1 PDLIM3 PDLIM5 PDLIM7 PDSS1 PDSS2 PFKM PGAM2 PGK1 PGM1 PHKA1 PLEC PLEKHG4 PLN PNPLA2 POLG POMGNT1 POMGNT2 POMK POMT1 POMT2 PRKAG2 PTRF PUS1 PYGM QDPR RAPSN RBCK1 RRM2B RYR1 SEPN1 SGCA SGCB SGCD SGCG SLC22A5 SLC25A20 SLC25A4 SMCHD1 SOX10 SPEG SQSTM1 SRF STIM1 SUCLA2 SYNE1 SYNE2 SYNE3 SYNPO2 SYT2 TCAP TIA1 TK2 TMEM5 TMOD3 TNNC1 TNNC2 TNNI1 TNNI2 TNNI3 TNNT1 TNNT3 TNPO3 TOR1AIP1 TPM1 TPM2 TPM3 TRAPPC11 TRIM32 TRIM55 TRIM63 TTN TTR VCP VMA21 YARS2 KCNJ2 SCN4A TMEM43 Peking University First Hospital AAAS AARS ABC1 ABCA1 ABCD1 ABHD12 ABHD5 ACAD8 ACADL ACADM ACADS ACADVL ACTA1 ACVR1 ADCK3 AGC1 AGL AGRN AIFM1 AIRE ALDOA ALDOB ALG1 ALG12 ALG13 ALG14 ALG2 ALG3 ALG6 ALG8 ALG9 ALS2 AMACR ANO5 APOA1 Zhong H, et al. J Med Genet 2020;0:1–8. doi: 10.1136/jmedgenet-2020-107159 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Med Genet ARHGEF10 ARL6IP1 ARSA ASAH1 ASL ATL1 ATL3 ATM ATP7A ATP7B B3GALNT2 B3GNT1 B4GALT1 BAG3 BICD2 BIN1 BSCL2 C10orf2 C7orf10 CACNA1A CACNA1C CACNA1S CACNB2 CACNL2D1 CAPN3 CASQ1 CAV3 CCDC78 CCT5 CFL2 CHAT CHCHD10 CHKB CHN1 CHRM3 CHRNA1 CHRNB CHRNB1 CHRND CHRNE CHRNG CLCN1 CLN3 CNTN1 COG1 COG7 COG8 COL12A1 COL25A1 COL6A1 COL6A2 COL6A3 COL9A2 COL9A3 COLQ COMP COQ2 COQ6 COQ9 COX6A1 CP CPT1A CPT2 CRAT CRYAB CTDP1 CUL4B DAG1 DCAF8 DCTN1 DECR1 DES DGUOK DHH DHTKD1 DMD DNAJB2 DNAJB6 DNAJC3 DNM2 DNMT1 DOK7 DOLK DPAGT1 DPM1 DPM2 DPM3 DST DYNC1H1 DYSF ECEL1 EGR2 EMD ENO3 EPM2A ETFA ETFB ETFDH ETHE1 EXOSC3 EXOSC8 FAM134B FBLN5 FBP1 FBXO38 FGA FGD4 FHL1 FIF1B FIG4 FKBP14 FKRP FKTN FLNA FLNC FLVCR1 FUS G6PC GAA GALC GALE GALK1 GALT GARS GBE1 GCH1 GCS1 GDAP1 GFPT1 GJB1 GJB3 GK GLA GLYCTK GMPPB GNB4 GNE GPD1L GYG1 GYS1 GYS2 HADH HADHA HADHB HAMP HARS HCN4 HEXA HFE HFE2 HINT1 HK1 HNRNPA1 HNRNPA2B1 HNRNPDL HNRPDL HOXA1 HOXD10 HRAS HSPB1 HSPB3 HSPB8 IFRD1 IGHMBP2 IKBKAP INF2 ISCU ISPD ITGA7 ITGA9 KARS KBTBD13 KCNA1 KCNE1 KCNE2 KCNE3 KCNH2 KCNJ16 KCNJ18 KCNJ2 KCNJ3 KCNJ5 KCNQ1 KHK KIF1A KIF21A KIF5A KLHL40 KLHL9 LAMA2 LAMB2 LAMP2 LARGE LAS1L LDB3 LDHA LDHB LDHC LDHM LIMS2 LITAF LMNA LPIN1 LRP4 LRSAM1 LYZ MAPT MARS MATR3 MED25 Zhong H, et al. J Med Genet 2020;0:1–8. doi: 10.1136/jmedgenet-2020-107159 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Med Genet MEGF10 MFN2 MGAT2 MLYCD MMACHC MOGS MPDU1 MPI MPZ MSTN MTAP MTM1 MTMR2 MTO1 MUSK MVK MYBPC1 MYBPC3 MYF6 MYH14 MYH2 MYH3 MYH7 MYH8 MYLK2 MYOT NAGLU NDRG1 NEB NEFL NGF NHLRC1 NIPA1 NTRK1 OPA1 ORAI1 OTC PABPN1 PDK3 PDSS1 PDSS2 PEX1 PEX7 PFKM PGAM2 PGK1 PGM1 PHKA1 PHKA2 PHKB PHKG2 PHOX2A PHYH PIEZO2 PLA2G6 PLEC PLEKHG5 PMM2 PMP22 PNPLA2 POLG POMGNT1 POMGNT2 POMK POMT1 POMT2 PREPL PRKAG2 PRKG2 PRNP PRPS1 PRX PTPLA PTRF PYGL PYGM RAB7A RAPSN RBCK1 RBM28 REEP1 RFT1 RNF170 RYR1 SALL4 SBF1 SBF2 SCN11A SCN1A SCN1B SCN3B SCN4A SCN4B SCN5A SCN9A SCO2 SCP2 SECISBP2 SEPN1 SGCA SGCB SGCD SGCE SGCG SGK196 SH3TC2 SIL1 SLC12A6 SLC22A5 SLC25A1 SLC25A12 SLC25A20 SLC25A3 SLC25A4 SLC2A2 SLC35A1 SLC35C1 SLC37A4 SLC40A1 SLC4A1 SLC5A7 SMCHD1 SMN1 SMN2 SNAP25 SOD1 SOX10 SPAST SPG11 SPTLC1 SPTLC2 STIM1 SURF1 TALDO1 TAZ TBX5 TCAP TDP1 TFG TGFB1 TH TIA1 TK2 TMEM43 TMEM5 TNNI2 TNNI3 TNNT1 TNNT2 TNNT3 TNPO3 TNXB TOR1AIP1 TPI1 TPM1 TPM2 TPM3 TRAPPC11 TRIM2 TRIM32 TRPV4 TTN TTR TUBB2B TUBB3 UBA1 UTRN VAPB VCP VMA21 VRK1 XK YARS ZBTB42 ZC4H2 Shandong University Qilu Hospital/ The Third Hospital of Hebei Medical University ACTA1 ACTG2 ACVR1 ADCY5 ADCY6 ADGRG6 AGRN ALG14 ALG2 AMPD1 ANO5 ATP2A1 B3GALNT2 B4GAT1 Zhong H, et al. J Med Genet 2020;0:1–8. doi: 10.1136/jmedgenet-2020-107159 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Med Genet BAG3 BIN1 BVES CACNA1A CACNA1S CAPN3 CASQ1 CASQ2 CAV3 CCDC78 CFL2 CHAT CHCHD10 CHKB CHMP1B CHRNA1 CHRNB1 CHRND CHRNE CLCN1 CNBP CNTN1 CNTNAP1 COA6 COL12A1 COL13A1 COL25A1 COL6A1 COL6A2 COL6A3 COLQ CPT2 CRYAB DAG1 DES DMD DMPK DNA2 DNAJB6 DNM2 DOK7 DPAGT1 DYSF ECEL1 EMD ERBB3 FAM111B FBN2 FHL1 FKBP14 FKRP FKTN FLAD1 FLNC GAMT GFER GFPT1 GLDN GLE1 GMPPB GNE GYG1 HACD1 HINT1 HNRNPA2B1 HNRNPDL HRAS ISCU ISPD ITGA7 KBTBD13 KCNA1 KCNA2 KCNE1 KCNE3 KCNH2 KCNJ16 KCNJ18 KCNJ2 KCNJ5 KCNQ1 KCNQ2 KIF21A KLHL40 KLHL41 KY LAMA2 LARGE1 LDB3 LIMS2 LMNA LMOD3 LPIN1 LRP4 MEGF10 MICU1 MSTN MTM1 MUSK MYBPC1 MYF6 MYH14 MYH2 MYH3 MYH7 MYH8 MYO18B MYOT MYPN NALCN NEB NEK9 NOL3 NOTCH3 OPA1 ORAI1 PABPN1 PDGFRB PHOX2A PIEZO2 PIP5K1C PLEC PNPLA2 PNPLA8 POGLUT1 POLG POLG2 POMGNT1 POMGNT2 POMK POMT1 POMT2 PREPL PUS1 PYROXD1 RAPSN RBCK1 RNASEH1 RRM2B RYR1 RYR2 SCN1A SCN4A SCN5A SELENON SGCA SGCB SGCD SGCE SGCG SLC18A3 SLC25A4 SLC5A7 SLC6A8 SMCHD1 SNAP25 SPEG STAC3 STIM1 SUCLA2 SYNE1 SYNE2 SYT2 TBCE TCAP TIA1 TMEM43 TMEM5 TNNI2 TNNT1 TNNT3 TNPO3 TOR1AIP1 TPM2 TPM3 TRAPPC11 TRDN TRIM32 TRIP4 TTN TUBB3 VIPAS39 VMA21 VPS33B YARS2 ZBTB42 Zhong H, et al. J Med Genet 2020;0:1–8. doi: 10.1136/jmedgenet-2020-107159.
Load more

Recommended publications
  • Supplemental Information to Mammadova-Bach Et Al., “Laminin Α1 Orchestrates VEGFA Functions in the Ecosystem of Colorectal Carcinogenesis”
    Supplemental information to Mammadova-Bach et al., “Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinogenesis” Supplemental material and methods Cloning of the villin-LMα1 vector The plasmid pBS-villin-promoter containing the 3.5 Kb of the murine villin promoter, the first non coding exon, 5.5 kb of the first intron and 15 nucleotides of the second villin exon, was generated by S. Robine (Institut Curie, Paris, France). The EcoRI site in the multi cloning site was destroyed by fill in ligation with T4 polymerase according to the manufacturer`s instructions (New England Biolabs, Ozyme, Saint Quentin en Yvelines, France). Site directed mutagenesis (GeneEditor in vitro Site-Directed Mutagenesis system, Promega, Charbonnières-les-Bains, France) was then used to introduce a BsiWI site before the start codon of the villin coding sequence using the 5’ phosphorylated primer: 5’CCTTCTCCTCTAGGCTCGCGTACGATGACGTCGGACTTGCGG3’. A double strand annealed oligonucleotide, 5’GGCCGGACGCGTGAATTCGTCGACGC3’ and 5’GGCCGCGTCGACGAATTCACGC GTCC3’ containing restriction site for MluI, EcoRI and SalI were inserted in the NotI site (present in the multi cloning site), generating the plasmid pBS-villin-promoter-MES. The SV40 polyA region of the pEGFP plasmid (Clontech, Ozyme, Saint Quentin Yvelines, France) was amplified by PCR using primers 5’GGCGCCTCTAGATCATAATCAGCCATA3’ and 5’GGCGCCCTTAAGATACATTGATGAGTT3’ before subcloning into the pGEMTeasy vector (Promega, Charbonnières-les-Bains, France). After EcoRI digestion, the SV40 polyA fragment was purified with the NucleoSpin Extract II kit (Machery-Nagel, Hoerdt, France) and then subcloned into the EcoRI site of the plasmid pBS-villin-promoter-MES. Site directed mutagenesis was used to introduce a BsiWI site (5’ phosphorylated AGCGCAGGGAGCGGCGGCCGTACGATGCGCGGCAGCGGCACG3’) before the initiation codon and a MluI site (5’ phosphorylated 1 CCCGGGCCTGAGCCCTAAACGCGTGCCAGCCTCTGCCCTTGG3’) after the stop codon in the full length cDNA coding for the mouse LMα1 in the pCIS vector (kindly provided by P.
    [Show full text]
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • LDB3 Monoclonal Antibody (M06), Gene Alias: CYPHER, FLJ35865, KIAA01613, Clone 3C8 KIAA0613, ORACLE, PDLIM6, ZASP, Ldb3z1, Ldb3z4
    LDB3 monoclonal antibody (M06), Gene Alias: CYPHER, FLJ35865, KIAA01613, clone 3C8 KIAA0613, ORACLE, PDLIM6, ZASP, ldb3z1, ldb3z4 Gene Summary: This gene encodes a PDZ Catalog Number: H00011155-M06 domain-containing protein. PDZ motifs are modular Regulatory Status: For research use only (RUO) protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins Product Description: Mouse monoclonal antibody interact with each other in cytoskeletal assembly or with raised against a full-length recombinant LDB3. other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene Clone Name: 3C8 interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM Immunogen: LDB3 (AAH10929, 1 a.a. ~ 283 a.a) domains. The LIM domain is a cysteine-rich motif full-length recombinant protein with GST tag. MW of the defined by 50-60 amino acids containing two GST tag alone is 26 KDa. zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this Sequence: gene have been associated with myofibrillar myopathy MSYSVTLTGPGPWGFRLQGGKDFNMPLTISRITPGSK and dilated cardiomyopathy. Alternatively spliced AAQSQLSQGDLVVAIDGVNTDTMTHLEAQNKIKSASY transcript variants encoding different isoforms have been NLSLTLQKSKRPIPISTTAPPVQTPLPVIPHQKVVVNSP identified; all isoforms have N-terminal PDZ domains ANADYQERFNPSALKDSALSTHKPIEVKGLGGKATIIHA while only longer isoforms (1 and 2) have C-terminal
    [Show full text]
  • A Rare Missense Mutation in GJB3 (Cx31g45e) Is Associated with a Unique Cellular Phenotype Resulting in Necrotic Cell Death Easton, J
    University of Dundee A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death Easton, J. A.; Alboulshi, A. K.; Kamps, M. A. F.; Brouns, G. H.; Broers, M. R.; Coull, B. J.; Oji, V.; van Geel, M.; van Steensel, M. A. M.; Martin, P. E. Published in: Experimental Dermatology DOI: 10.1111/exd.13542 Publication date: 2018 Document Version Peer reviewed version Link to publication in Discovery Research Portal Citation for published version (APA): Easton, J. A., Alboulshi, A. K., Kamps, M. A. F., Brouns, G. H., Broers, M. R., Coull, B. J., ... Martin, P. E. (2018). A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death. Experimental Dermatology. https://doi.org/10.1111/exd.13542 General rights Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain. • You may freely distribute the URL identifying the publication in the public portal. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Targeted Genes and Methodology Details for Neuromuscular Genetic Panels
    Targeted Genes and Methodology Details for Neuromuscular Genetic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Neuromuscular Genetic Panels Next-generation sequencing (NGS) and/or Sanger sequencing is performed Motor Neuron Disease Panel to test for the presence of a mutation in these genes. Gene GenBank Accession Number Regions of homology, high GC-rich content, and repetitive sequences may ALS2 NM_020919 not provide accurate sequence. Therefore, all reported alterations detected ANG NM_001145 by NGS are confirmed by an independent reference method based on laboratory developed criteria. However, this does not rule out the possibility CHMP2B NM_014043 of a false-negative result in these regions. ERBB4 NM_005235 Sanger sequencing is used to confirm alterations detected by NGS when FIG4 NM_014845 appropriate.(Unpublished Mayo method) FUS NM_004960 HNRNPA1 NM_031157 OPTN NM_021980 PFN1 NM_005022 SETX NM_015046 SIGMAR1 NM_005866 SOD1 NM_000454 SQSTM1 NM_003900 TARDBP NM_007375 UBQLN2 NM_013444 VAPB NM_004738 VCP NM_007126 ©2018 Mayo Foundation for Medical Education and Research Page 1 of 14 MC4091-83rev1018 Muscular Dystrophy Panel Muscular Dystrophy Panel Gene GenBank Accession Number Gene GenBank Accession Number ACTA1 NM_001100 LMNA NM_170707 ANO5 NM_213599 LPIN1 NM_145693 B3GALNT2 NM_152490 MATR3 NM_199189 B4GAT1 NM_006876 MYH2 NM_017534 BAG3 NM_004281 MYH7 NM_000257 BIN1 NM_139343 MYOT NM_006790 BVES NM_007073 NEB NM_004543 CAPN3 NM_000070 PLEC NM_000445 CAV3 NM_033337 POMGNT1 NM_017739 CAVIN1 NM_012232 POMGNT2
    [Show full text]
  • Downloaded from NCBI Website [31]
    Int. J. Mol. Sci. 2014, 15, 21788-21802; doi:10.3390/ijms151221788 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Interactome Mapping Reveals Important Pathways in Skeletal Muscle Development of Pigs Jianhua Cao, Tinghua Huang, Xinyun Li and Shuhong Zhao * Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education of China, College of Animal Science and Technology, Huazhong Agricultural University, 1 Shizishan St., Wuhan 430070, China; E-Mails: [email protected] (J.C.); [email protected] (T.H.); [email protected] (X.L.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +86-27-8738-7480; Fax: +86-27-8728-0408. External Editor: Mark L. Richter Received: 15 July 2014; in revised form: 19 October 2014 / Accepted: 6 November 2014 / Published: 26 November 2014 Abstract: The regulatory relationship and connectivity among genes involved in myogenesis and hypertrophy of skeletal muscle in pigs still remain large challenges. Presentation of gene interactions is a potential way to understand the mechanisms of developmental events in skeletal muscle. In this study, genome-wide transcripts and miRNA profiling was determined for Landrace pigs at four time points using microarray chips. A comprehensive method integrating gene ontology annotation and interactome network mapping was conducted to analyze the biological patterns and interaction modules of muscle development events based on differentially expressed genes and miRNAs. Our results showed that in total 484 genes and 34 miRNAs were detected for the duration from embryonic stage to adult in pigs, which composed two linear expression patterns with consensus changes.
    [Show full text]
  • Nrf2 Modulates Host Defense During Streptococcus Pneumoniae Pneumonia in Mice
    Nrf2 Modulates Host Defense during Streptococcus pneumoniae Pneumonia in Mice This information is current as John C. Gomez, Hong Dang, Jessica R. Martin and Claire of September 28, 2021. M. Doerschuk J Immunol published online 26 August 2016 http://www.jimmunol.org/content/early/2016/08/26/jimmun ol.1600043 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2016/08/26/jimmunol.160004 Material 3.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published August 26, 2016, doi:10.4049/jimmunol.1600043 The Journal of Immunology Nrf2 Modulates Host Defense during Streptococcus pneumoniae Pneumonia in Mice John C. Gomez,*,† Hong Dang,†,‡ Jessica R. Martin,*,† and Claire M. Doerschuk*,†,x Nrf2 regulates the transcriptional response to oxidative stress. These studies tested the role of Nrf2 during Streptococcus pneumoniae pneumonia and identified Nrf2-dependent genes and pathways in lung tissue and in recruited neutrophils.
    [Show full text]
  • The Role of Z-Disc Proteins in Myopathy and Cardiomyopathy
    International Journal of Molecular Sciences Review The Role of Z-disc Proteins in Myopathy and Cardiomyopathy Kirsty Wadmore 1,†, Amar J. Azad 1,† and Katja Gehmlich 1,2,* 1 Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK; [email protected] (K.W.); [email protected] (A.J.A.) 2 Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK * Correspondence: [email protected]; Tel.: +44-121-414-8259 † These authors contributed equally. Abstract: The Z-disc acts as a protein-rich structure to tether thin filament in the contractile units, the sarcomeres, of striated muscle cells. Proteins found in the Z-disc are integral for maintaining the architecture of the sarcomere. They also enable it to function as a (bio-mechanical) signalling hub. Numerous proteins interact in the Z-disc to facilitate force transduction and intracellular signalling in both cardiac and skeletal muscle. This review will focus on six key Z-disc proteins: α-actinin 2, filamin C, myopalladin, myotilin, telethonin and Z-disc alternatively spliced PDZ-motif (ZASP), which have all been linked to myopathies and cardiomyopathies. We will summarise pathogenic variants identified in the six genes coding for these proteins and look at their involvement in myopathy and cardiomyopathy. Listing the Minor Allele Frequency (MAF) of these variants in the Genome Aggregation Database (GnomAD) version 3.1 will help to critically re-evaluate pathogenicity based on variant frequency in normal population cohorts.
    [Show full text]
  • Supplemental Table S1
    Entrez Gene Symbol Gene Name Affymetrix EST Glomchip SAGE Stanford Literature HPA confirmed Gene ID Profiling profiling Profiling Profiling array profiling confirmed 1 2 A2M alpha-2-macroglobulin 0 0 0 1 0 2 10347 ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7 1 0 0 0 0 3 10350 ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9 1 0 0 0 0 4 10057 ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 1 0 0 0 0 5 10060 ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 1 0 0 0 0 6 79575 ABHD8 abhydrolase domain containing 8 1 0 0 0 0 7 51225 ABI3 ABI gene family, member 3 1 0 1 0 0 8 29 ABR active BCR-related gene 1 0 0 0 0 9 25841 ABTB2 ankyrin repeat and BTB (POZ) domain containing 2 1 0 1 0 0 10 30 ACAA1 acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiol 0 1 0 0 0 11 43 ACHE acetylcholinesterase (Yt blood group) 1 0 0 0 0 12 58 ACTA1 actin, alpha 1, skeletal muscle 0 1 0 0 0 13 60 ACTB actin, beta 01000 1 14 71 ACTG1 actin, gamma 1 0 1 0 0 0 15 81 ACTN4 actinin, alpha 4 0 0 1 1 1 10700177 16 10096 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 0 1 0 0 0 17 94 ACVRL1 activin A receptor type II-like 1 1 0 1 0 0 18 8038 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 1 0 0 0 0 19 8751 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 1 0 0 0 0 20 8728 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 1 0 0 0 0 21 81792 ADAMTS12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 1 0 0 0 0 22 9507 ADAMTS4 ADAM metallopeptidase with thrombospondin type 1
    [Show full text]
  • Genetic Mutations and Mechanisms in Dilated Cardiomyopathy
    Genetic mutations and mechanisms in dilated cardiomyopathy Elizabeth M. McNally, … , Jessica R. Golbus, Megan J. Puckelwartz J Clin Invest. 2013;123(1):19-26. https://doi.org/10.1172/JCI62862. Review Series Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of congestive heart failure. In hypertrophic cardiomyopathy (HCM), cardiac output is limited by the thickened myocardium through impaired filling and outflow. Mutations in the genes encoding the thick filament components myosin heavy chain and myosin binding protein C (MYH7 and MYBPC3) together explain 75% of inherited HCMs, leading to the observation that HCM is a disease of the sarcomere. Many mutations are “private” or rare variants, often unique to families. In contrast, dilated cardiomyopathy (DCM) is far more genetically heterogeneous, with mutations in genes encoding cytoskeletal, nucleoskeletal, mitochondrial, and calcium-handling proteins. DCM is characterized by enlarged ventricular dimensions and impaired systolic and diastolic function. Private mutations account for most DCMs, with few hotspots or recurring mutations. More than 50 single genes are linked to inherited DCM, including many genes that also link to HCM. Relatively few clinical clues guide the diagnosis of inherited DCM, but emerging evidence supports the use of genetic testing to identify those patients at risk for faster disease progression, congestive heart failure, and arrhythmia. Find the latest version: https://jci.me/62862/pdf Review series Genetic mutations and mechanisms in dilated cardiomyopathy Elizabeth M. McNally, Jessica R. Golbus, and Megan J. Puckelwartz Department of Human Genetics, University of Chicago, Chicago, Illinois, USA. Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of conges- tive heart failure.
    [Show full text]
  • Genequery™ Human Skeletal Muscle Contraction And
    GeneQuery™ Human Skeletal Muscle Contraction and Muscular Dystrophies qPCR Array Kit (GQH-SKC) Catalog #GK065 Product Description ScienCell's GeneQuery™ Human Skeletal Muscle Contraction and Muscular Dystrophies qPCR Array (GQH-SKC) profiles 88 key genes involved in the contraction of skeletal muscle. There are three major muscle types in the human body: skeletal, cardiac, and smooth. Skeletal muscle is a striated muscle that relaxes and contracts to generate movement and force in the body. Of the three main muscle types, it is the only one under voluntary control. Neuromuscular diseases involving skeletal muscle dysfunction are very diverse and range from myopathies to muscular dystrophies. Below are brief examples of how included genes may be grouped according to their function in skeletal muscle biology: • Myogenesis: MYOD1, MYOG, PAX3, UTRN, MYF6, MDTN • Contractility: MYH2, SLC2A4, LMNA, DYSF, APT2A1 • Sarcomere Assembly : NEB, TRIM63, TTN, CAPN3, ACTA1 • Muscle Atrophy: NOS2, TRIM63, FOXO1, MAPK8, AKT1 • Muscular Dystrophy Development: POMT2, FKRP, ANO5, FRG1, SGCB Note : all gene names follow their official symbols by the Human Genome Organization Gene Nomenclature Committee (HGNC). GeneQuery™ qPCR array kits are qPCR ready in a 96-well plate format, with each well containing one primer set that can specifically recognize and efficiently amplify a target gene's cDNA. The carefully designed primers ensure that: (i) the optimal annealing temperature in qPCR analysis is 65°C (with 2 mM Mg 2+ , and no DMSO); (ii) the primer set recognizes all known transcript variants of target gene, unless otherwise indicated; and (iii) only one gene is amplified. Each primer set has been validated by qPCR with melt curve analysis, and gel electrophoresis.
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]